跳至主要内容
临床试验/CTRI/2012/08/002869
CTRI/2012/08/002869已完成未知

An open label clinical trial to study the efficacy and safety of BioMinox A DD for the treatment of dandruff and hair loss

Sante Mernaud Pharmaceuticals Pvt Ltd0 个研究点目标入组 15 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Males and females of age group 18-50 years
  • Subjects who are suffering from mild to moderate dandruff and hair loss.
  • Subjects who are willing to give written informed consent

排除标准

  • Any dermatological condition of the scalp other than hair loss and /or dandruff.
  • Any prior hair growth procedures (e.g., hair transplant or laser)
  • History of alcohol or drug addiction
  • History of skin allergy
  • Any active skin infection in the scalp area or scarring in the target area.
  • Subject had ever received radiation therapy to the scalp, or had chemotherapy within the past year.
  • Subject had participated in any investigational study within the 30 days prior to trial.
  • A history or the presence of any serious and/or chronic medical condition(s) including psychiatric illnesses] which, in the opinion of the investigator, may cause harm to the individual and/or compromise/confound the study results.
  • Subjects unwilling or unable to comply with the study procedures

研究者

发起方
Sante Mernaud Pharmaceuticals Pvt Ltd

相似试验